Status:
COMPLETED
Pharmaceutical Care for Asthma Control Improvement (PHARMACI)-Study
Lead Sponsor:
University Ghent
Conditions:
Asthma
Eligibility:
All Genders
18-50 years
Phase:
NA
Brief Summary
The objective of this study is to evaluate the therapeutic effectiveness and cost-effectivity of pharmaceutical care for asthma patients.
Detailed Description
The objective of this study is to evaluate the therapeutic effectiveness and cost-effectivity of pharmaceutical care for asthma patients. Patients will be randomly allocated to the control group (= no...
Eligibility Criteria
Inclusion
- Patients with persistent asthma
- Asthma treatment for at least 12 months
- Regular visitors of the participating community pharmacy
Exclusion
- Severe co-morbidity
- \> 10 pack-years smoking history
- Asthma Control Test score \< 15 or =25
Key Trial Info
Start Date :
January 1 2006
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
October 1 2006
Estimated Enrollment :
221 Patients enrolled
Trial Details
Trial ID
NCT00263159
Start Date
January 1 2006
End Date
October 1 2006
Last Update
December 28 2007
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University Hospital Ghent
Ghent, Belgium, 9000